Autologous T Cell | List of Frontiers open access articles

Original Research

Published on 01 Aug 2022

CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro

in Cancer Immunity and Immunotherapy

Farid Ghorbaninezhad
Javad Masoumi
Mohammad Bakhshivand
Amir Baghbanzadeh
Ahad Mokhtarzadeh
Tohid Kazemi
Leili Aghebati-Maleki
Siamak Sandoghchian Shotorbani
Mahdi Jafarlou
Oronzo Brunetti

Frontiers in Immunology

doi 10.3389/fimmu.2022.931316

6,457 views
23 citations

Clinical Trial

Published on 14 Nov 2022

Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial

in Infectious Diseases: Pathogenesis and Therapy

Nidal Muvarak
Haishan Li
Tyler Lahusen
Jeffrey A. Galvin
Princy N. Kumar
C. David Pauza
José Bordon

Frontiers in Medicine

doi 10.3389/fmed.2022.1044713

22,180 views
8 citations

Review

Published on 12 Jun 2025

Allogeneic CART progress: platforms, current progress and limitations

in Cancer Immunity and Immunotherapy

Ameneh Shokati
Maryam Sanjari-Pour
Mahshid Akhavan Rahnama
Saghar Hoseinzadeh
Mohammad Vaezi
Mohammad Ahmadvand

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557157

7,525 views
8 citations

Original Research

Published on 26 May 2022

Halophilic Archaea Halorhabdus Rudnickae and Natrinema Salaciae Activate Human Dendritic Cells and Orient T Helper Cell Responses

in Microbial Immunology

Krzysztof T. Krawczyk
Camille Locht
Magdalena Kowalewicz-Kulbat

Frontiers in Immunology

doi 10.3389/fimmu.2022.833635

5,471 views
8 citations

Original Research

Published on 16 Mar 2022

Endoplasmic Reticulum Stress of Oral Squamous Cell Carcinoma Induces Immunosuppression of Neutrophils

in Radiation Oncology

Ching-Fang Wu
Tzu-Ting Hung
Yu-Chieh Su
Po-Jen Chen
Kuei-Hung Lai
Chih-Chun Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.818192

3,866 views
8 citations

Original Research

Published on 14 Feb 2018

Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry

in Immunological Tolerance and Regulation

Silvia Rodriguez-Fernandez
Irma Pujol-Autonell
Ferran Brianso
David Perna-Barrull
Mary Cano-Sarabia
Sonia Garcia-Jimeno
Adrian Villalba
Alex Sanchez
Eva Aguilera
Federico Vazquez

Frontiers in Immunology

doi 10.3389/fimmu.2018.00253

17,215 views
73 citations

Original Research

Published on 10 Jul 2018

Lactobacillus rhamnosus GG-Derived Soluble Mediators Modulate Adaptive Immune Cells

in Nutritional Immunology

Irene S. Ludwig
Femke Broere
Sarmauli Manurung
Tim T. Lambers
Ruurd van der Zee
Willem van Eden

Frontiers in Immunology

doi 10.3389/fimmu.2018.01546

9,449 views
40 citations

Original Research

Published on 14 Aug 2023

Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity

in Cancer Immunity and Immunotherapy

Mary L. Faber
Robyn A. A. Oldham
Archana Thakur
Mary Jo Rademacher
Ewa Kubicka
Theresa A. Dlugi
Steven A. Gifford
William M. McKillop
Nathan J. Schloemer
Lawrence G. Lum

Frontiers in Immunology

doi 10.3389/fimmu.2023.1225610

9,053 views
9 citations

Articles

CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro

Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial

Allogeneic CART progress: platforms, current progress and limitations

Halophilic Archaea Halorhabdus Rudnickae and Natrinema Salaciae Activate Human Dendritic Cells and Orient T Helper Cell Responses

Endoplasmic Reticulum Stress of Oral Squamous Cell Carcinoma Induces Immunosuppression of Neutrophils

Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry

Lactobacillus rhamnosus GG-Derived Soluble Mediators Modulate Adaptive Immune Cells

Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity